REFERENCES
- Gustafsson J. BCDrive performance vs. conventional bone conduction transducer. Cochlear Bone Anchored Solutions AB, 629908, 2015.
- Niparko JK, Cox KM, Lustig LR. Comparison of the bone-anchored hearing aid implantable hearing device with contralateral routing of offside signal amplification in the rehabilitation of unilateral deafness. Otology & Neurotology, 2003 Jan;24(1):73-78.
- den Besten CA, Monksfield P, Bosman A, Skarzynski PH, Green K, Runge C, Wigren S, Blechert JI, Flynn MC, Mylanus EAM, Hol MK. Audiological and clinical outcomes of a transcutaneous bone conduction hearing implant: six-month results from a multicentre study. Clin Otolaryngol. 2018 Oct 25. doi: 10.1111/coa.13248. [Epub ahead of print].
- Wazen JJ, Spitzer JB, Ghossaini SN, Fayad JN, Niparko JK, Cox K, et al. Transcranial contralateral cochlear stimulation in unilateral deafness. Otolaryngology-Head & Neck Surgery 2003;129(3):248-54.
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
*Views expressed are those of the individual. Consult your hearing health provider to determine if you are a candidate for Cochlear technology.
Cochlear, Hear now. And always, Nucleus, Kanso, Baha, Osia, the elliptical logo, and marks bearing an ® or ™ symbol, are either trademarks or registered trademarks of Cochlear Limited or Cochlear Bone Anchored Solutions AB (unless otherwise noted).
D1870211-V1